Fresh fears for new expedited pathway readiness Just weeks away from the launch of AHPRA’s new fast-tracked IMG program, the RACGP says details of its systems, processes, and resources remain unclear.
Canberra Independents commit to GP incentives A coalition of ACT politicians announced a plan to rollout $40,000 packages for GPs, and the RACGP is urging other parties to do the same.
GPs @ Parliament takes over Tasmania GPs hosted a pop-up clinic inside Parliament House, offering politicians a blood pressure check and a one-on-one chat about the need for change.
In Practice: Medicines safety resources The RACGP has a new education toolkit and on-demand recordings for GPs in their role of reducing medicine-related harm.
What do GPs need to know about ‘walking’ pneumonia? With a current ‘soup’ of respiratory infections coupled with antibiotic shortages, an epidemiologist outlines basic advice for GPs.
Only 29% of clinical guidelines offer advice on deprescribing Researchers believe clinicians should have more support, but a prominent GP says numerous barriers make this a difficult proposition.
Study links Ozempic to kidney failure prevention It found semaglutide reduced risk of major kidney events by 24% for type 2 diabetes patients, but GPs have urged caution.
Replica Ozempic and Mounjaro to be banned The Government has removed a loophole allowing the mass production of the compounded drugs amid growing patient safety concerns.
Concerns raised over possible change to medicine advertising rules The RACGP calls for greater transparency and larger fines for breaches in a review of Medicines Australia’s code of conduct.
ADHD med shortage set to end Supplies of lisdexamfetamine dimesilate should return to normal levels by the end of April, the TGA has advised.